22 May 2013
Keywords: GlaxoSmithKline, Theravance, Anoro, UMEC/VI, EU filing, COPD
Article | 10 January 2013
UK pharma giant GlaxoSmithKline (LSE: GSK) and US partner Theravance (Nasdaq: THRX) yesterday submitted a regulatory application in the European ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
10 January 2013
21 May 2013
© 2013 thepharmaletter.com